The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Pierre P. Massion

Division of Allergy

Pulmonary and Critical Care Medicine

Vanderbilt-Ingram Cancer Center

2220 Pierce Avenue

USA. E-mail:

[email]@vanderbilt.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, USA. E-mail:. 2006 - 2012
  • Corresponding Author: Pierre P. Massion, Thoracic Center, Nashville Veterans Affairs, Tennessee Valley Healthcare System. 2012
  • Department of Medicine, The Vanderbilt Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, 2200 Pierce Avenue, USA. 2003 - 2004

References

  1. Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis. Ocak, S., Pedchenko, T.V., Chen, H., Harris, F.T., Qian, J., Polosukhin, V., Pilette, C., Sibille, Y., Gonzalez, A.L., Massion, P.P. Eur. Respir. J. (2012) [Pubmed]
  2. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Pecot, C.V., Li, M., Zhang, X.J., Rajanbabu, R., Calitri, C., Bungum, A., Jett, J.R., Putnam, J.B., Callaway-Lane, C., Deppen, S., Grogan, E.L., Carbone, D.P., Worrell, J.A., Moons, K.G., Shyr, Y., Massion, P.P. Cancer Epidemiol. Biomarkers Prev. (2012) [Pubmed]
  3. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. Massion, P.P., Zou, Y., Uner, H., Kiatsimkul, P., Wolf, H.J., Baron, A.E., Byers, T., Jonsson, S., Lam, S., Hirsch, F.R., Miller, Y.E., Franklin, W.A., Varella-Garcia, M. PLoS. ONE (2009) [Pubmed]
  4. Smoking-related genomic signatures in non-small cell lung cancer. Massion, P.P., Zou, Y., Chen, H., Jiang, A., Coulson, P., Amos, C.I., Wu, X., Wistuba, I., Wei, Q., Shyr, Y., Spitz, M.R. Am. J. Respir. Crit. Care Med. (2008) [Pubmed]
  5. Proteomic strategies for the characterization and the early detection of lung cancer. Massion, P.P., Caprioli, R.M. J. Thorac. Oncol (2006) [Pubmed]
  6. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Massion, P.P., Taflan, P.M., Shyr, Y., Rahman, S.M., Yildiz, P., Shakthour, B., Edgerton, M.E., Ninan, M., Andersen, J.J., Gonzalez, A.L. Am. J. Respir. Crit. Care Med. (2004) [Pubmed]
  7. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Massion, P.P., Taflan, P.M., Jamshedur Rahman, S.M., Yildiz, P., Shyr, Y., Edgerton, M.E., Westfall, M.D., Roberts, J.R., Pietenpol, J.A., Carbone, D.P., Gonzalez, A.L. Cancer Res. (2003) [Pubmed]
  8. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications. Massion, P.P., Carbone, D.P. Respir. Res. (2003) [Pubmed]
 
WikiGenes - Universities